Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings per share (EPS) is N/A as of Tuesday, October 6, 2026.
EARNINGS PER SHARE (EPS)
N/A
Latigo Biotherapeutics Inc.
Market Cap
$1.01B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$998.31M
Earnings Per Share (EPS)
-2.97
TTM Avg
-9.41
3Y Avg
-6.16
5Y Avg
-6.16
Market Cap
$993.70M
Earnings Per Share (EPS)
0.71
TTM Avg
-1.77
3Y Avg
-1.98
5Y Avg
-1.86
Market Cap
$1.02B
Earnings Per Share (EPS)
-0.38
TTM Avg
-0.83
3Y Avg
-0.98
5Y Avg
-0.98
Market Cap
$990.91M
Earnings Per Share (EPS)
-1.94
TTM Avg
-1.73
3Y Avg
-1.92
5Y Avg
-1.76
Market Cap
$988.29M
Earnings Per Share (EPS)
0.35
TTM Avg
-0.99
3Y Avg
-0.18
5Y Avg
0.61
Market Cap
$987.50M
Earnings Per Share (EPS)
-1.05
TTM Avg
-1.23
3Y Avg
-0.94
5Y Avg
-0.94
Market Cap
$1.03B
Earnings Per Share (EPS)
-0.09
TTM Avg
-3.41
3Y Avg
-0.94
5Y Avg
-0.03
Market Cap
$1.04B
Earnings Per Share (EPS)
-1.84
TTM Avg
-0.83
3Y Avg
-0.99
5Y Avg
-2.01
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Latigo Biotherapeutics Inc. (LTGO) | $1.01B | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $998.31M | -2.97 | -9.41 | -6.16 | -6.16 |
| MeiraGTx Holdings plc (MGTX)vs › | $993.70M | 0.71 | -1.77 | -1.98 | -1.86 |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | -0.38 | -0.83 | -0.98 | -0.98 |
| PROCEPT BioRobotics Corporation (PRCT)vs › | $990.91M | -1.94 | -1.73 | -1.92 | -1.76 |
| Pacira BioSciences, Inc. (PCRX)vs › | $988.29M | 0.35 | -0.99 | -0.18 | 0.61 |
| Aktis Oncology, Inc. (AKTS)vs › | $987.50M | -1.05 | -1.23 | -0.94 | -0.94 |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.03B | -0.09 | -3.41 | -0.94 | -0.03 |
| Immatics N.V. (IMTX)vs › | $1.04B | -1.84 | -0.83 | -0.99 | -2.01 |
| Castle Biosciences, Inc. (CSTL)vs › | $1.04B | -0.66 | -0.08 | -1.22 | -1.11 |
Trailing EPS (TTM)
N/A
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
